推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

IL-1β Is Overexpressed and Aberrantly Regulated in Corticosteroid Nonresponders with Autoimmune Inner Ear Disease

[HTML] from nih.govS Pathak, E Goldofsky, EX Vivas… - The Journal of …, 2011 - Am Assoc Immnol
Autoimmune inner ear disease is an enigmatic disorder characterized by recurring episodes
of sudden or progressive sensorineural hearing loss. Hearing loss can be improved by timely
corticosteroid administration, but only half of those treated respond, and for many ...
Related articles - All 5 versions

Autoimmune Inner Ear Disease in Children

NC Huang… - Otology & Neurotology, 2011 - journals.lww.com
Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining
your privacy and will not share your personal information without your express consent. For more
information, please refer to our Privacy Policy. ... Objective: To determine the response to ...
Related articles - All 4 versions

High dose combination pertussis toxin induces autoimmune inner ear disease in Sprague-Dawley rats

WJ Kong, DY Wang, X Huang… - Acta Oto- …, 2011 - informahealthcare.com
Conclusion: A better animal model of autoimmune inner ear disease (AIED) in Sprague-Dawley
rats has been developed by combination with high dose of pertussis toxin. This study also indicated
that inner ear-specific antigens can be involved in autoimmune reactions. Cell-mediated ...
Related articles - All 3 versions

Extraintestinal Crohn's Disease Mimicking Autoimmune Inner Ear Disease: A Histopathological Approach

M Dettmer, I Hegemann… - Audiology and …, 2011 - content.karger.com
Patients with autoimmune inner ear disease develop rapidly progressive sensorineural hearing
loss over a period of several weeks or months, often accompanied by vestibular loss. This disease
can occur as a distinct clinical entity or in association with an underlying autoimmune ...
Cited by 1 - Related articles - All 3 versions

[HTML] Otologic Manifestation in IgG4-Related Systemic Disease

[HTML] from nih.govHK Cho, YJ Lee, JH Chung… - Clinical and Experimental …, 2011 - ncbi.nlm.nih.gov
... discontinuation of steroids (3, 4). In cases of autoimmune inner ear disease, maintenance dose
is continued for a variable time but the patients with treatment duration of fewer than 6 months
are at increased risk of relapse compared with those treated for 6 months or longer. ...
Related articles - All 8 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451